Stocklytics Platform
Asset logo for symbol CABA
Cabaletta Bio
CABA51
$3.16arrow_drop_up1.60%$0.05
Penny Stock
Asset logo for symbol CABA
CABA51

$3.16

arrow_drop_up1.60%
Key Stats
Open$3.17
Prev. Close$3.11
EPS-2.16
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$152.00M
PE Ratio-
LOWHIGH
Day Range3.16
3.19
52 Week Range1.76
26.35
Ratios
Revenue-
EBITDA Margin %-
EPS-2.16
Fundamentals
Gross Profit-
Payout Ratio-
Industry average yield2.72%
Last Dividend pay date-
Dividend per share-
Dividend yield forecast-

Stock Analysis

Technicals

Summarizing what the indicators are suggesting.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Analyst rating

An aggregate view of professional's ratings.

Strong Buy
Buy
Neutral
Sell
Strong Sell

Stock Performance

CABA-
US Healthcare Sector-
US Market-
check_circle

CABA / Market

CABA exceeded the US Market which returned -0.72% over the last twenty four hours.
warning

CABA / Healthcare Sector

CABA lose to the US Healthcare sector which returned 2.71% over the last twenty four hours.

Cabaletta Bio (CABA) Statistics

Cabaletta Bio Inc (CABA) is a biotechnology company that focuses on the development of cell therapies for the treatment of B cell-mediated autoimmune diseases. The company is headquartered in Radnor, Pennsylvania. Cabaletta Bio Inc has a market capitalization of $XXX million as of [date].
When looking at the valuation metrics for Cabaletta Bio Inc, it is important to consider factors such as the company's price to earnings (P/E) ratio, price to sales (P/S) ratio, and price to book (P/B) ratio. These metrics can provide insights into the company's current valuation relative to its earnings, sales, and book value per share.
add Cabaletta Bio  to watchlist

Keep an eye on Cabaletta Bio

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

How has Cabaletta Bio (CABA) stock's performance compared to its sector and the market over the past year?

Over the past year, Cabaletta Bio (CABA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 28.98%, Cabaletta Bio has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 61.13%, it has fallen short of the market average. This comparison highlights Cabaletta Bio 's performance relative to both its sector and the overall market over the last year.
help

What is the PE ratio of Cabaletta Bio (CABA) stock?

The PE ratio for Cabaletta Bio (CABA) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help

What is the EPS of Cabaletta Bio (CABA) stock?

The Earnings Per Share (EPS) for Cabaletta Bio (CABA), calculated on a diluted basis, is -$2.16. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help

What is the operating margin of Cabaletta Bio (CABA) stock?

The operating margin for Cabaletta Bio (CABA) is 0%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help

What is the EBITDA of Cabaletta Bio (CABA) stock?

The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Cabaletta Bio (CABA) is -$98.61M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help

How much debt does Cabaletta Bio (CABA) have?

Cabaletta Bio (CABA) has a total debt of $7.4M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$155.38M.

Take Your Investments to a Whole New Level